CollPlant and United Therapeutics announce licensing and commercialization agreement
CollPlant and United Therapeutics announced a license, development and commercialization agreement for 3D bioprinted lung transplants. The agreement combines CollPlant's proprietary rhCollagen and BioInk technology with the regenerative medicine and manufacturing capabilities of United Therapeutics. October 22, 2018